研究体外反搏治疗对老年高血压合并射血分数降低心力衰竭患者心功能指标的影响

Investigating the Effect of Extracorporeal Counterpulsation Therapy on Cardiac Function Indicators in Elderly Patients with Hypertension and Heart Failure with Reduced Ejection Fraction

摘要: 目的：探讨体外反搏(EECP)治疗对老年高血压合并射血分数降低心力衰竭(HFrEF)患者心功能的影响。方法：按照治疗方案的不同将内蒙古自治区人民医院在2024年7月至2025年7月期间收治的70例老年高血压合并HFrEF患者分为对照组(n = 35)和EECP组(n = 35)。对对照组患者进行常规的药物治疗，对治疗组患者在进行常规药物治疗的基础上进行EECP治疗。然后对比两组患者心功能指标[左心室射血分数(LVEF)、左心室舒张末期内径(LVEDD)、左心室收缩末期经、N末端B型脑钠肽前体(NT-proBNP)、心功能级别、6分钟步行实验]。结果：治疗后，EECP组左心室射血分数(LVEF)、心功能级别、6分钟步行实验高于对照组，LVEDD、NT-proBNP、左心室收缩末期经均低于对照组(p < 0.05)。结论：对老年高血压合并HFrEF患者在常规治疗基础上联合EECP治疗，可显著改善心功能，提高生活质量。

Abstract: Objective: This study aims to investigate the effect of extracorporeal counterpulsation therapy on cardiac function in elderly patients with hypertension and heart failure with reduced ejection fraction. Abstract: This study explores the effect of extracorporeal counterpulsation therapy on cardiac function in elderly hypertensive patients with Heart Failure with Reduced Ejection Fraction (HFrEF). Methods: A total of 70 elderly hypertensive patients with HFrEF admitted to Inner Mongolia Autonomous Region People’s Hospital from July 2024 to July 2025 were divided into two groups according to different treatment regimens: the control group (n = 35) and the EECP group (n = 35). Patients in the control group received conventional drug therapy, while those in the EECP group received EECP therapy on the basis of conventional drug therapy. Cardiac function indices were compared between the two groups, including Left Ventricular Ejection Fraction (LVEF), Left Ventricular End-Diastolic Diameter (LVEDD), Left Ventricular End-Systolic Diameter, N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP), New York Heart Association (NYHA) Functional Class, and 6-Minute Walk Test (6 MWT). Results: After treatment, the LVEF, NYHA functional class, and 6 MWT results in the EECP group were significantly higher than those in the control group, while LVEDD, NT-proBNP, and Left Ventricular End-Systolic Diameter were significantly lower (all p < 0.05). Conclusion: Combined EECP therapy on the basis of conventional treatment can significantly improve cardiac function and quality of life in elderly hypertensive patients with HFrEF.